Literature DB >> 21894412

The impact of blood transfusion on morbidity and mortality after cardiac surgery.

Camila de Christo Dorneles1, Luiz Carlos Bodanese, João Carlos Vieira da Costa Guaragna, Fabrício Edler Macagnan, Juliano Cé Coelho, Anibal Pires Borges, Marco Antonio Goldani, João Batista Petracco.   

Abstract

OBJECTIVES: To analyze the impact of blood transfusion on the incidence of clinical outcomes postoperatively (PO) from cardiac surgery.
METHODS: Retrospective cohort study. We analyzed 4028 patients undergoing coronary artery bypass grafting (CABG), valve (TV), or both, in Brazilian tertiary university hospital between 1996 and 2009. We compared the postoperative complications between patients with blood transfusion (n = 916) and non-blood transfusion (n = 3112). Univariate analysis was performed using the Student t test, and multivariate logistic regression bivariate (stepwise forward). Were considered significant variables with P <0.05.
RESULTS: Patients who received blood transfusions had more infectious episodes as mediastinitis (4.9% vs. 2.2%, P <0.001), respiratory infection (27.8% vs 17.1%, P <0.001) and sepsis (6.2% vs. 2.5%, P <0.001). There were more episodes of atrial fibrillation (AF) (27% vs. 20.4%, P <0.001), acute renal failure (ARF) (14.5% vs 7.3%, P <0.001) and stroke (4.8% vs. 2.6%, P = 0.001). The length of PO hospital stay was higher in transfused (13 ± 12.07 days vs. 9.72 ± 7.66 days, P <0.001). However, mortality didn't differ between groups (10.9% vs. 9.1%, P = 0.112). The transfusion was shown to be a risk factor for: respiratory infection (OR: 1.91, 95% CI 1.59-2.29, P <0.001), AF (OR: 1.35, 95% CI 1.13-1.61, P = 0.01), sepsis (OR: 2.08, 95% CI 1.4-3.07, P <0.001), mediastinitis (OR: 2.14, 95% CI: 1.43-3.21, P <0.001), stroke (OR: 1.63, 95% CI 1.1-2.41, P = 0.014) and ARF (OR 1.8, 95% CI: 1.39-2.33, P <0.001).
CONCLUSION: The blood transfusion is associated with increased risk of infectious events, episodes of AF, ARF and stroke, as well as the increased length of hospital stay but not mortality.

Entities:  

Mesh:

Year:  2011        PMID: 21894412     DOI: 10.1590/s0102-76382011000200012

Source DB:  PubMed          Journal:  Rev Bras Cir Cardiovasc


  10 in total

1.  Effects of circuit residual volume salvage reinfusion on the postoperative clinical outcome for pediatric patients undergoing cardiac surgery.

Authors:  Lifen Ye; Ru Lin; Yong Fan; Lijun Yang; Jianling Hu; Qiang Shu
Journal:  Pediatr Cardiol       Date:  2012-12-13       Impact factor: 1.655

2.  Impact of aspirin use on morbidity and mortality in massively transfused cardiac surgery patients: a propensity score matched cohort study.

Authors:  Michael Mazzeffi; Samuel Galvagno; James S Gammie; Kenichi Tanaka
Journal:  J Anesth       Date:  2016-07-05       Impact factor: 2.078

Review 3.  Blood transfusion and infection after cardiac surgery.

Authors:  Keith A Horvath; Michael A Acker; Helena Chang; Emilia Bagiella; Peter K Smith; Alexander Iribarne; Irving L Kron; Pamela Lackner; Michael Argenziano; Deborah D Ascheim; Annetine C Gelijns; Robert E Michler; Danielle Van Patten; John D Puskas; Karen O'Sullivan; Dorothy Kliniewski; Neal O Jeffries; Patrick T O'Gara; Alan J Moskowitz; Eugene H Blackstone
Journal:  Ann Thorac Surg       Date:  2013-05-03       Impact factor: 4.330

4.  Impact of respiratory infection in the results of cardiac surgery in a tertiary hospital in Brazil.

Authors:  Isaac Newton Guimarães Andrade; Diego Torres Aladin de Araújo; Fernando Ribeiro de Moraes Neto
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jul-Sep

5.  Benefit from using recycling red blood cells in cardiovascular surgery.

Authors:  Mariah Steinbach; Mauricio H Z Centenaro; Rui M S Almeida
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Jul-Sep

Review 6.  Therapeutic options to minimize allogeneic blood transfusions and their adverse effects in cardiac surgery: a systematic review.

Authors:  Antônio Alceu dos Santos; José Pedro da Silva; Luciana da Fonseca da Silva; Alexandre Gonçalves de Sousa; Raquel Ferrari Piotto; José Francisco Baumgratz
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Oct-Dec

7.  Clinical and Surgical Strategies for Avoiding or Reducing Allogeneic Blood Transfusions.

Authors:  Antonio Alceu Dos Santos; Jose Francisco Baumgratz; Jose Henrique Andrade Vila; Rodrigo Moreira Castro; Rodrigo Freire Bezerra
Journal:  Cardiol Res       Date:  2016-05-04

8.  Predictors of Mediastinitis Risk after Coronary Artery Bypass Surgery: Applicability of Score in 1.322 Cases.

Authors:  Fabiana Dos Santos Oliveira; Letícia Delfino Oliveira de Freitas; Eneida Rejane Rabelo-Silva; Laura Maggi da Costa; Renato Abdala Karam Kalil; Maria Antonieta Pereira de Moraes
Journal:  Arq Bras Cardiol       Date:  2017-08-17       Impact factor: 2.000

9.  The lymphocyte/monocyte ratio and red blood cell transfusion during radical retropubic prostatectomy.

Authors:  Jun-Young Park; Jihion Yu; Bumjin Lim; Jiwoong Lee; Jai-Hyun Hwang; Yongsoo Lee; Young-Kug Kim
Journal:  J Anesth       Date:  2021-10-08       Impact factor: 2.078

10.  Mortality risk is dose-dependent on the number of packed red blood cell transfused after coronary artery bypass graft.

Authors:  Antônio Alceu dos Santos; Alexandre Gonçalves Sousa; Raquel Ferrari Piotto; Juan Carlos Montano Pedroso
Journal:  Rev Bras Cir Cardiovasc       Date:  2013 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.